Apollomics (APLM) Stock Chart & Stock Price History $6.23 +0.08 (+1.30%) Closing price 04:00 PM EasternExtended Trading$6.29 +0.06 (+0.96%) As of 04:46 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisChartCompetitorsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Apollomics Stock Price Performance The Apollomics (APLM) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 69.65%, with a year-to-date return of -36.10%. In the past month, the stock has decreased 1.11%, reflecting recent market activity. As of the latest close, Apollomics traded at $6.15 with a market cap of $6.78 million and volume of 101,214 shares. Receive APLM Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Apollomics and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+0.32%1 Month Performance-1.11%3 Month Performance-6.74%Year-To-Date Performance-36.10%1 Year Performance-69.65% APLM Stock Chart for Friday, July, 25, 2025 APLM Chart by TradingView Apollomics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization07/24/2025$5.97$6.15+3.02%$6.30$4.73101,214 shs$6.78 million07/23/2025$6.50$5.97-8.15%$6.02$5.5032,041 shs$6.57 million07/22/2025$7.07$6.50-8.06%$7.22$6.2728,403 shs$7.15 million07/21/2025$6.21$7.07+13.85%$8.18$6.64532,872 shs$7.80 million07/18/2025$6.45$6.21-3.72%$6.45$6.0014,120 shs$6.83 million07/17/2025$6.01$6.45+7.32%$6.45$5.926,147 shs$7.11 million07/16/2025$6.00$6.01+0.17%$6.04$5.752,682 shs$6.61 million07/15/2025$5.74$6.00+4.53%$6.00$5.506,677 shs$6.62 million07/14/2025$5.45$5.74+5.32%$6.00$5.337,636 shs$6.33 million07/11/2025$5.70$5.45-4.39%$5.92$5.1113,075 shs$6.01 million Get the Latest News and Ratings for APLM and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Apollomics and its competitors with MarketBeat's FREE daily newsletter. 07/10/2025$5.76$5.70-1.04%$6.00$5.3418,279 shs$6.27 million07/09/2025$6.54$5.76-11.93%$6.50$5.33357,423 shs$6.34 million07/08/2025$6.44$6.54+1.55%$6.54$6.293,778 shs$7.21 million07/07/2025$6.51$6.44-1.00%$6.56$6.045,939 shs$7.08 million07/04/2025$6.51$6.51$6.50$6.0534,939 shs$7.18 million07/03/2025$6.35$6.51+2.44%$6.50$6.0534,939 shs$7.16 million07/02/2025$6.38$6.35-0.39%$6.56$6.56426 shs$6.99 million07/01/2025$6.56$6.38-2.82%$6.56$6.352,184 shs$7.01 million06/30/2025$6.51$6.56+0.77%$6.60$6.2144,758 shs$7.22 million06/27/2025$6.41$6.51+1.56%$6.70$6.268,492 shs$7.16 million06/26/2025$6.30$6.41+1.75%$6.80$6.4012,204 shs$7.07 million06/25/2025$6.63$6.30-4.98%$6.75$6.004,371 shs$6.93 million06/24/2025$5.52$6.63+20.02%$6.70$5.4215,481 shs$7.29 million Related Companies MIRA Pharmaceuticals Stock Chart Tenax Therapeutics Stock Chart Rani Therapeutics Stock Chart Cadrenal Therapeutics Stock Chart Cara Therapeutics Stock Chart Q32 Bio Stock Chart BioAtla Stock Chart Sol-Gel Technologies Stock Chart Lisata Therapeutics Stock Chart JATT Acquisition Stock Chart Receive APLM Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Apollomics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:APLM) was last updated on 7/25/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredTrump’s betrayal exposed Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredHow to Collect Up To $5,917/mo From Trump’s Made In USA BoomHow to Collect Up To $5,917/mo From Trump's Made In USA Boom Thanks to President Trump's America-First poli...Investors Alley | SponsoredHedge fund legend humiliates Bitcoin tradersLarry Benedict made $274 million trading on Wall Street… Barron’s ranked his hedge fund in the top 1% world...Brownstone Research | SponsoredThe big winner of Crypto week?It’s Crypto Week at the White House — and the sector is moving from fringe to full-scale adoption. With Bit...Weiss Ratings | SponsoredHere's the last trade you should make before heading out for the weekend tomorrow.Make this one trade at 2:59 PM on Friday afternoon, and you'll thank me on Monday morning.Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Apollomics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Apollomics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
